p38 mapk inhibitor sb203580 sb (MedChemExpress)
Structured Review
P38 Mapk Inhibitor Sb203580 Sb, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 98/100, based on 531 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p38+mapk/Adezmapimod/pm42153350-40-1-9
Average 98 stars, based on 531 article reviews
Images
Related Articles
Infection:Article Title: Insufficient CXCL13 secretion in leprosy foamy macrophages attenuates lymphocyte recruitment and antimicrobial protein production. Article Snippet: THP-1 cells were differentiated into macrophages by PMA (200 ng/ml, Abcam). .. The cells were then pretreated with BAY 11-7085/ BAY 11-7083 (HY-10257, MCE), or Article Title: Insufficient CXCL13 secretion in leprosy foamy macrophages attenuates lymphocyte recruitment and antimicrobial protein production Article Snippet: THP-1 cells were differentiated into macrophages by PMA (200 ng/ml, Abcam). .. The cells were then pretreated with BAY 11-7085/BAY 11-7083 (HY-10257, MCE), or Injection:Article Title: Escherichia coli promotes colorectal cancer metastasis by maintaining enhancer-promoter loops through releasing neutrophil extracellular traps Article Snippet: .. 3 d after the injection of MC38 cells or patient organoids, Anti-CD3 Antibody (OKT-3) (3 mg/kg, HY-P990864, MedChemExpress, NJ, USA), Anumigilimab (2 mg/kg, HY-P99440, MedChemExpress), Ca 2+ channel agonist 1 (4 mg/kg, HY-41076, MedChemExpress), Clodronate Liposomes (40337ES08, Yeasen, China), DMSO (HY-Y0320C, MedChemExpress), DNase I (10 mg/kg, 10104159001, Merck), GSK484 hydrochloride (4 mg/kg, HY-100514, MedChemExpress), GSK583 (4 mg/kg, HY-100339, MedChemExpress), InVivoMAb anti-mouse CD3ε (5 mg/kg, catalog number: BE0001-1, clone name: 145-2C11, Bio X Cell, PA, USA), InVivoMAb anti-mouse Ly6G (5 mg/kg, catalog number: BE0075, clone name: RB6-8C5, Bio X Cell), InVivoMAb rat IgG2a isotype control (5 mg/kg, catalog number: BE0251, clone name: RG7/1.30, Bio X Cell), JNK-IN-8 (3 mg/kg, HY-13319, MedChemExpress), JSH-23 (5 mg/kg, HY-13982, MedChemExpress), MLKL-IN-1 (5 mg/kg, HY-139878, MedChemExpress), NOD1/2 antagonist-1 (5 mg/kg, HY-146034, MedChemExpress), Paquinimod (5 mg/kg, HY-100442, MedChemExpress), PMA (5 mg/kg, P8139, Merck), Article Title: Escherichia coli promotes colorectal cancer metastasis by maintaining enhancer-promoter loops through releasing neutrophil extracellular traps. Article Snippet: The specific details of this procedure were outlined as follows: After 3 d of the injection of MC38 cells or patient organoids, the bacteria (5 × 107 CFU/mouse in 100 μL DPBS) was injected into the posterior wall of the anus once every day for a total of ten times. (5) To eliminate the bacterial flora in mice, mice were orally fed with antibiotic premix (1 mL/kg/d, Metronidazole (1 mg/mL, M1547, Merck), Ampicillin (1 mg/mL, A5354, Merck), Neomycin (1 mg/mL, AR TI CL E IN P RE SS N1142, Merck), Gentamicin (1 mg/mL, G1914, Merck), and Vancomycin (0.5 mg/mL, V2002, Merck)) daily, and antibiotic premix (50 μL/mL) was added to the drinking water for 16 d. We used Normal Saline as the control. (6) Small molecule compound treatment: Before commencing the formal experiment, we gathered dosage data for the same drug or its structural analogues in mice of the same strain, emphasizing consistency in the administration route and experimental model. .. 3 d after the injection of MC38 cells or patient organoids, Anti-CD3 Antibody (OKT-3) (3 mg/kg, HY-P990864, MedChemExpress, NJ, USA), Anumigilimab (2 mg/kg, HY-P99440, MedChemExpress), Ca2+ channel agonist 1 (4 mg/kg, HY-41076, MedChemExpress), Clodronate Liposomes (40337ES08, Yeasen, China), DMSO (HY-Y0320C, MedChemExpress), DNase I (10 mg/kg, 10104159001, Merck), GSK484 hydrochloride (4 mg/kg, HY-100514, MedChemExpress), GSK583 (4 mg/kg, HY-100339, MedChemExpress), InVivoMAb anti-mouse CD3ε (5 mg/kg, catalog number: BE0001-1, clone name: 145-2C11, Bio X Cell, PA, USA), InVivoMAb anti-mouse Ly6G (5 mg/kg, catalog number: BE0075, clone name: RB6-8C5, Bio X Cell), InVivoMAb rat IgG2a isotype control (5 mg/kg, catalog number: BE0251, clone name: RG7/1.30, Bio X Cell), JNK-IN-8 (3 mg/kg, HY-13319, MedChemExpress), JSH23 (5 mg/kg, HY-13982, MedChemExpress), MLKL-IN-1 (5 mg/kg, HY-139878, MedChemExpress), NOD1/2 antagonist-1 (5 mg/kg, HY-146034, MedChemExpress), Paquinimod (5 mg/kg, HY-100442, MedChemExpress), PMA (5 mg/kg, P8139, Merck), Liposomes:Article Title: Escherichia coli promotes colorectal cancer metastasis by maintaining enhancer-promoter loops through releasing neutrophil extracellular traps Article Snippet: .. 3 d after the injection of MC38 cells or patient organoids, Anti-CD3 Antibody (OKT-3) (3 mg/kg, HY-P990864, MedChemExpress, NJ, USA), Anumigilimab (2 mg/kg, HY-P99440, MedChemExpress), Ca 2+ channel agonist 1 (4 mg/kg, HY-41076, MedChemExpress), Clodronate Liposomes (40337ES08, Yeasen, China), DMSO (HY-Y0320C, MedChemExpress), DNase I (10 mg/kg, 10104159001, Merck), GSK484 hydrochloride (4 mg/kg, HY-100514, MedChemExpress), GSK583 (4 mg/kg, HY-100339, MedChemExpress), InVivoMAb anti-mouse CD3ε (5 mg/kg, catalog number: BE0001-1, clone name: 145-2C11, Bio X Cell, PA, USA), InVivoMAb anti-mouse Ly6G (5 mg/kg, catalog number: BE0075, clone name: RB6-8C5, Bio X Cell), InVivoMAb rat IgG2a isotype control (5 mg/kg, catalog number: BE0251, clone name: RG7/1.30, Bio X Cell), JNK-IN-8 (3 mg/kg, HY-13319, MedChemExpress), JSH-23 (5 mg/kg, HY-13982, MedChemExpress), MLKL-IN-1 (5 mg/kg, HY-139878, MedChemExpress), NOD1/2 antagonist-1 (5 mg/kg, HY-146034, MedChemExpress), Paquinimod (5 mg/kg, HY-100442, MedChemExpress), PMA (5 mg/kg, P8139, Merck), Article Title: Escherichia coli promotes colorectal cancer metastasis by maintaining enhancer-promoter loops through releasing neutrophil extracellular traps. Article Snippet: The specific details of this procedure were outlined as follows: After 3 d of the injection of MC38 cells or patient organoids, the bacteria (5 × 107 CFU/mouse in 100 μL DPBS) was injected into the posterior wall of the anus once every day for a total of ten times. (5) To eliminate the bacterial flora in mice, mice were orally fed with antibiotic premix (1 mL/kg/d, Metronidazole (1 mg/mL, M1547, Merck), Ampicillin (1 mg/mL, A5354, Merck), Neomycin (1 mg/mL, AR TI CL E IN P RE SS N1142, Merck), Gentamicin (1 mg/mL, G1914, Merck), and Vancomycin (0.5 mg/mL, V2002, Merck)) daily, and antibiotic premix (50 μL/mL) was added to the drinking water for 16 d. We used Normal Saline as the control. (6) Small molecule compound treatment: Before commencing the formal experiment, we gathered dosage data for the same drug or its structural analogues in mice of the same strain, emphasizing consistency in the administration route and experimental model. .. 3 d after the injection of MC38 cells or patient organoids, Anti-CD3 Antibody (OKT-3) (3 mg/kg, HY-P990864, MedChemExpress, NJ, USA), Anumigilimab (2 mg/kg, HY-P99440, MedChemExpress), Ca2+ channel agonist 1 (4 mg/kg, HY-41076, MedChemExpress), Clodronate Liposomes (40337ES08, Yeasen, China), DMSO (HY-Y0320C, MedChemExpress), DNase I (10 mg/kg, 10104159001, Merck), GSK484 hydrochloride (4 mg/kg, HY-100514, MedChemExpress), GSK583 (4 mg/kg, HY-100339, MedChemExpress), InVivoMAb anti-mouse CD3ε (5 mg/kg, catalog number: BE0001-1, clone name: 145-2C11, Bio X Cell, PA, USA), InVivoMAb anti-mouse Ly6G (5 mg/kg, catalog number: BE0075, clone name: RB6-8C5, Bio X Cell), InVivoMAb rat IgG2a isotype control (5 mg/kg, catalog number: BE0251, clone name: RG7/1.30, Bio X Cell), JNK-IN-8 (3 mg/kg, HY-13319, MedChemExpress), JSH23 (5 mg/kg, HY-13982, MedChemExpress), MLKL-IN-1 (5 mg/kg, HY-139878, MedChemExpress), NOD1/2 antagonist-1 (5 mg/kg, HY-146034, MedChemExpress), Paquinimod (5 mg/kg, HY-100442, MedChemExpress), PMA (5 mg/kg, P8139, Merck), Control:Article Title: Escherichia coli promotes colorectal cancer metastasis by maintaining enhancer-promoter loops through releasing neutrophil extracellular traps Article Snippet: .. 3 d after the injection of MC38 cells or patient organoids, Anti-CD3 Antibody (OKT-3) (3 mg/kg, HY-P990864, MedChemExpress, NJ, USA), Anumigilimab (2 mg/kg, HY-P99440, MedChemExpress), Ca 2+ channel agonist 1 (4 mg/kg, HY-41076, MedChemExpress), Clodronate Liposomes (40337ES08, Yeasen, China), DMSO (HY-Y0320C, MedChemExpress), DNase I (10 mg/kg, 10104159001, Merck), GSK484 hydrochloride (4 mg/kg, HY-100514, MedChemExpress), GSK583 (4 mg/kg, HY-100339, MedChemExpress), InVivoMAb anti-mouse CD3ε (5 mg/kg, catalog number: BE0001-1, clone name: 145-2C11, Bio X Cell, PA, USA), InVivoMAb anti-mouse Ly6G (5 mg/kg, catalog number: BE0075, clone name: RB6-8C5, Bio X Cell), InVivoMAb rat IgG2a isotype control (5 mg/kg, catalog number: BE0251, clone name: RG7/1.30, Bio X Cell), JNK-IN-8 (3 mg/kg, HY-13319, MedChemExpress), JSH-23 (5 mg/kg, HY-13982, MedChemExpress), MLKL-IN-1 (5 mg/kg, HY-139878, MedChemExpress), NOD1/2 antagonist-1 (5 mg/kg, HY-146034, MedChemExpress), Paquinimod (5 mg/kg, HY-100442, MedChemExpress), PMA (5 mg/kg, P8139, Merck), Article Title: Effects of Mytilus edulis derived plasmalogens against atherosclerosis via lipid metabolism and MAPK signaling pathway Article Snippet: .. Subsequently, the membranes were washed with TBST three times, and incubated with the following primary antibodies: β-actin (HY- P80438 , MedChemExpress, Monmouth Junction, NJ, USA), Article Title: Escherichia coli promotes colorectal cancer metastasis by maintaining enhancer-promoter loops through releasing neutrophil extracellular traps. Article Snippet: The specific details of this procedure were outlined as follows: After 3 d of the injection of MC38 cells or patient organoids, the bacteria (5 × 107 CFU/mouse in 100 μL DPBS) was injected into the posterior wall of the anus once every day for a total of ten times. (5) To eliminate the bacterial flora in mice, mice were orally fed with antibiotic premix (1 mL/kg/d, Metronidazole (1 mg/mL, M1547, Merck), Ampicillin (1 mg/mL, A5354, Merck), Neomycin (1 mg/mL, AR TI CL E IN P RE SS N1142, Merck), Gentamicin (1 mg/mL, G1914, Merck), and Vancomycin (0.5 mg/mL, V2002, Merck)) daily, and antibiotic premix (50 μL/mL) was added to the drinking water for 16 d. We used Normal Saline as the control. (6) Small molecule compound treatment: Before commencing the formal experiment, we gathered dosage data for the same drug or its structural analogues in mice of the same strain, emphasizing consistency in the administration route and experimental model. .. 3 d after the injection of MC38 cells or patient organoids, Anti-CD3 Antibody (OKT-3) (3 mg/kg, HY-P990864, MedChemExpress, NJ, USA), Anumigilimab (2 mg/kg, HY-P99440, MedChemExpress), Ca2+ channel agonist 1 (4 mg/kg, HY-41076, MedChemExpress), Clodronate Liposomes (40337ES08, Yeasen, China), DMSO (HY-Y0320C, MedChemExpress), DNase I (10 mg/kg, 10104159001, Merck), GSK484 hydrochloride (4 mg/kg, HY-100514, MedChemExpress), GSK583 (4 mg/kg, HY-100339, MedChemExpress), InVivoMAb anti-mouse CD3ε (5 mg/kg, catalog number: BE0001-1, clone name: 145-2C11, Bio X Cell, PA, USA), InVivoMAb anti-mouse Ly6G (5 mg/kg, catalog number: BE0075, clone name: RB6-8C5, Bio X Cell), InVivoMAb rat IgG2a isotype control (5 mg/kg, catalog number: BE0251, clone name: RG7/1.30, Bio X Cell), JNK-IN-8 (3 mg/kg, HY-13319, MedChemExpress), JSH23 (5 mg/kg, HY-13982, MedChemExpress), MLKL-IN-1 (5 mg/kg, HY-139878, MedChemExpress), NOD1/2 antagonist-1 (5 mg/kg, HY-146034, MedChemExpress), Paquinimod (5 mg/kg, HY-100442, MedChemExpress), PMA (5 mg/kg, P8139, Merck), Incubation:Article Title: Effects of Mytilus edulis derived plasmalogens against atherosclerosis via lipid metabolism and MAPK signaling pathway Article Snippet: .. Subsequently, the membranes were washed with TBST three times, and incubated with the following primary antibodies: β-actin (HY- P80438 , MedChemExpress, Monmouth Junction, NJ, USA), Electrochemiluminescence:Article Title: Effects of Mytilus edulis derived plasmalogens against atherosclerosis via lipid metabolism and MAPK signaling pathway Article Snippet: .. Subsequently, the membranes were washed with TBST three times, and incubated with the following primary antibodies: β-actin (HY- P80438 , MedChemExpress, Monmouth Junction, NJ, USA), Mouse Assay:Article Title: Escherichia coli promotes colorectal cancer metastasis by maintaining enhancer-promoter loops through releasing neutrophil extracellular traps. Article Snippet: The specific details of this procedure were outlined as follows: After 3 d of the injection of MC38 cells or patient organoids, the bacteria (5 × 107 CFU/mouse in 100 μL DPBS) was injected into the posterior wall of the anus once every day for a total of ten times. (5) To eliminate the bacterial flora in mice, mice were orally fed with antibiotic premix (1 mL/kg/d, Metronidazole (1 mg/mL, M1547, Merck), Ampicillin (1 mg/mL, A5354, Merck), Neomycin (1 mg/mL, AR TI CL E IN P RE SS N1142, Merck), Gentamicin (1 mg/mL, G1914, Merck), and Vancomycin (0.5 mg/mL, V2002, Merck)) daily, and antibiotic premix (50 μL/mL) was added to the drinking water for 16 d. We used Normal Saline as the control. (6) Small molecule compound treatment: Before commencing the formal experiment, we gathered dosage data for the same drug or its structural analogues in mice of the same strain, emphasizing consistency in the administration route and experimental model. .. 3 d after the injection of MC38 cells or patient organoids, Anti-CD3 Antibody (OKT-3) (3 mg/kg, HY-P990864, MedChemExpress, NJ, USA), Anumigilimab (2 mg/kg, HY-P99440, MedChemExpress), Ca2+ channel agonist 1 (4 mg/kg, HY-41076, MedChemExpress), Clodronate Liposomes (40337ES08, Yeasen, China), DMSO (HY-Y0320C, MedChemExpress), DNase I (10 mg/kg, 10104159001, Merck), GSK484 hydrochloride (4 mg/kg, HY-100514, MedChemExpress), GSK583 (4 mg/kg, HY-100339, MedChemExpress), InVivoMAb anti-mouse CD3ε (5 mg/kg, catalog number: BE0001-1, clone name: 145-2C11, Bio X Cell, PA, USA), InVivoMAb anti-mouse Ly6G (5 mg/kg, catalog number: BE0075, clone name: RB6-8C5, Bio X Cell), InVivoMAb rat IgG2a isotype control (5 mg/kg, catalog number: BE0251, clone name: RG7/1.30, Bio X Cell), JNK-IN-8 (3 mg/kg, HY-13319, MedChemExpress), JSH23 (5 mg/kg, HY-13982, MedChemExpress), MLKL-IN-1 (5 mg/kg, HY-139878, MedChemExpress), NOD1/2 antagonist-1 (5 mg/kg, HY-146034, MedChemExpress), Paquinimod (5 mg/kg, HY-100442, MedChemExpress), PMA (5 mg/kg, P8139, Merck), TUNEL Assay:Article Title: Ferulic Acid Combines with Ascorbic Acid to Target MMP9 to Attenuate Cisplatin-Induced Ototoxicity Through the p38MAPK Signaling Pathway Article Snippet: Paraformaldehyde (4%) and enhanced chemiluminescence detection (ECL) reagents were purchased from Biosharp (Hefei, China). .. A One-step TUNEL Apoptosis Detection Kit (C1088) was purchased from Biyuntian Biotechnology Co., Ltd. (Shanghai, China). Article Title: Ferulic Acid Combines with Ascorbic Acid to Target MMP9 to Attenuate Cisplatin-Induced Ototoxicity Through the p38MAPK Signaling Pathway. Article Snippet: Paraformaldehyde (4%) and enhanced chemiluminescence detection (ECL) reagents were purchased from Biosharp (Hefei, China). .. A One-step TUNEL Apoptosis Detection Kit (C1088) was purchased from Biyuntian Biotechnology Co., Ltd. (Shanghai, China). Blocking Assay:Article Title: TRIM38 Alleviates Ferroptosis in Heart Failure by Inactivating the TRAF6-p38 MAPK Pathway via Ubiquitinating Degradation of IRAK1. Article Snippet: This article explored the role of TRIM38 in ferroptosis in heart failure (HF) and its underlying mechanisms.. Methodologically, serum TRIM38, IRAK1 and TRAF6 proteins from HF patients were detected by Western blot.. In an in vitro study, an HF cell model was established by inducing H9c2 cells with doxorubicin. |

